An interventional study of Internet delivered Acceptance and Commitment therapy and Waiting list control condition in Chronic Pain, sponsored by Rikard Wicksell. Completed at 1 site in Sweden. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-01-03.
Sponsored by Rikard Wicksell · Not applicable, Interventional, and Treatment
The overall aim of the present study is to evaluate an internet-delivered Acceptance and Commitment therapy treatment (iACT) for patients with chronic pain. More specifically, the study will evaluate if 1) iACT is effective in improving functioning and quality of life in comparison to a waitlist condition, 2) if iACT is cost-effective, 3) factors that influence treatment outcome (i.e. predictors, moderators or characteristics of treatment responders), 4) if psychological variables mediates the effects of treatment on outcome, and 5) if subgroups of patients varies in change processes (i.e. moderated mediation).
The main hypothesis is that iACT will improve functioning and quality of life.
Chronic pain affects 12-30% of the population and often results in depression, disability, and reduced quality of life. Medical strategies are often ineffective or insufficient to alleviate symptoms and increase functioning. Instead, the empirical support for cognitive behavior therapy (CBT) is today well established, and such interventions are commonly seen as critically important for patients with chronic pain. However, modest effects sizes calls for further improvements. Recent developments within CBT, particularly Acceptance and Commitment Therapy (ACT), have suggested the utility of acceptance and mindfulness strategies to manage pain and distress. The body of evidence for ACT has grown rapidly during the past decade, and ACT is today listed by the American Psychological Association as a treatment for chronic pain, with strong empirical support.
Internet-delivered ACT
Despite the increased empirical support for ACT the availability is still very limited, and a large number of patients do not receive this treatment. In other domains, the accessibility of empirically supported treatments has increased during the past decade due to the development of methods to deliver the treatment via internet. For example, a large number of studies illustrate the utility of internet-delivered CBT for anxiety, insomnia and depression, with treatment effects similar to those obtained in studies with face-to-face treatment. Few studies have yet evaluated internet-delivered ACT (iACT) for chronic pain, but a recent pilot study from our group with participants suffering from fibromyalgia (n=41) illustrated very promising results that warrant further studies to evaluate the effects of this treatment.
Moderators and mediators of treatment outcome
If iACT shows to be effective, it is vital to identify for whom this treatment works. For example, it is possible that factors such as age, pain duration or depression may moderate the effects of treatment. Also, it is likely that some individuals who respond well to regular face-to-face treatment do not benefit from internet-delivered interventions. Furthermore, recent studies have shown that acceptance of pain and distress may be a more important mediator of change than e.g. pain intensity, catastrophizing or anxiety. However, no study has to our knowledge yet explored if subgroups of patients (e.g. men and women) improve via different change processes (i.e. moderated mediation). More information regarding moderators and mediators of change will make it possible to adjust and tailor interventions to meet specific individual needs, and thereby increase the effects of treatment.
Recruitment
Patients will be recruited through self referral. Thus, information regarding the study will be provided through newspapers and social media, as well as in direct communication with pain clinics and primary care units, including instructions regarding e.g. eligibility and how to sign up. Once patients have been found eligible and expressed interest in study participation they will be assessed by a psychologist, and when needed by a pain physician, via semi-structured interviews to confirm eligibility and to ensure that the patient meet the study criteria. Informed consent is obtained from all participants prior to the assessment.
Statistical methods
Evaluations of treatment effects are primarily based on intent-to-treat analyses. The statistical approach will primarily be based on linear multilevel modeling (LMM), which takes into account dependencies between repeated measures and differences between patients in pre-treatment status and treatment response (i.e. random effects modeling) and also provide means of handling missing data. More traditional methods, such as ANOVA and hierarchical regression, may also be utilized when appropriate. Analyses of change processes (mediation, moderation, moderated mediation) will follow guidelines and recommendations (e.g. cross-product of coefficients approach, bootstrapping). The main health economic outcomes will be the incremental cost-effectiveness ratio, which is a measure of the relationship between the cost of the treatment and the incremental value it provides in terms of functioning, compared to the control condition.
3,227 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.
This study's enrollment of 113 is above the median of 60 across 2,388 interventional studies indexed under Chronic Pain.
Browse Chronic Pain studies →Rikard Wicksell is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Internet delivered Acceptance and Commitment therapy, supported by a psychologist/psychology student under supervision.
Behavioral: Internet delivered Acceptance and Commitment therapy
Participants receive no treatment for ten weeks, i.e. waiting list condition. Following post-assessment, the control condition receive unguided iACT (i.e. the same content and structure as iACT but without systematic therapist communication).
Behavioral: Waiting list control condition
The main component in the treatment is exposure to symptoms and feared situations. The iACT program is adapted from the evidence based face-to-face treatment at the Behavioral Medicine unit at Karolinska University Hospital. The iACT program has a different structure but is equal in content to face-to-face treatment, and is to be completed within ten weeks. Participants receive texts, audio files, movies and exercises and have online contact with their psychologist via an internet platform or a smart phone application. The treatment aims to encourage valued behaviors in the presence of inner discomfort.
Also known as: iACT
After a ten week wait list period, the control condition receive same treatment as the intervention group, but without therapist support.
Pain Interference Index (changes between assessments)
Self rated measure of daily functioning related to pain
Time frame: Baseline, 10 weekly ratings, post (10 weeks), follow ups three, six and twelve months post treatment
The Valuing Questionnaire (changes)
Self rated progress and obstacles in valued actions
Time frame: Baseline, mid (4 weeks), post (10 weeks), follow ups three, six and twelve months post treatment
Psychological Inflexibility in Pain Scale (changes)
Self rated psychological inflexibility related to pain
Time frame: Baseline, 10 weekly ratings, post (10 weeks), follow ups three, six and twelve months post treatment
Patient Health Questionnaire 9 (changes)
Self rated depressive symptoms
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
European Quality of Life Five Dimensions Questionnaire (changes)
Self rated quality of life
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Insomnia Severity Index (changes)
Self rated degree of insomnia
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Pain Intensity (changes)
Self rated degree of pain during the last week on a scale from 0-10
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Occupational status (changes)
Self reported occupational status indicated on a pre specified list, including sick leave and/or retirement
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Perceived Stress Scale - 4 items (changes)
Self rated level of perceived stress
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
General Anxiety Disorder - 7 item (changes)
Self rated symptoms of general anxiety
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Medication use (changes)
Self reported medicine use
Time frame: Baseline, post (10 weeks), follow ups three, six and twelve months post treatment
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2017 to primary completion in Oct 2018, 19 months.
Of 1,295 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's 19 months is close to that.
Counting every sponsor, half of 1,378 studies reached it within 20 months; a quarter within 9 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.